StayCurrentMD · Vacuum-assisted closure (VAC) prevents wound dehiscence following posterior sagittal anorectoplasty (PSARP): An exploratory case–control study
Article1 min read·Published Aug 2020Older

Vacuum-assisted closure (VAC) prevents wound dehiscence following posterior sagittal anorectoplasty (PSARP): An exploratory case–control study

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Aug 2020 · 1 min read

In brief

In brief

Retrospective dual-center study of 38 children with anorectal malformations demonstrates that postoperative vacuum-assisted closure (VAC) therapy reduces wound dehiscence from 25% to 0% following posterior sagittal anorectoplasty. VAC application, combined with bowel preparation and supportive care, shows promise for preventing anocutaneous anastomotic breakdown without device-related complications.

Written by the GCMD Library team from the article.

Abstract

Background

Wound dehiscence (WD) of the anocutaneous anastomosis or perineal body after posterior sagittal anorectoplasty (PSARP) is common. We aimed to evaluate the efficacy of a perineal vacuum-assisted closure (VAC) for prevention of WD following repair of anorectal malformations (ARM) with rectoperineal and rectovestibular fistula.

Methods

A retrospective dual-center case–control study of children undergoing PSARP without colostomy between 2011 and 2019 was performed. The VAC group received preoperative bowel preparation (PBP), postoperative application of a VAC, loperamide (only Location A), intravenous antibiotics (IA), and total parenteral nutrition (TPN). The non-VAC group underwent PBP, loperamide (Location A), IA, and TPN without VAC. Primary outcome was WD at the anocutaneous anastomosis or reconstructed perineal body within the first 14 days after surgery.

Results

The study population included 18 patients (VAC group) and 20 children (non-VAG group) with rectoperineal and rectovestibular fistula. The incidence of WD in the VAC group was 0% compared to 25% in the non-VAC group (0/18 vs. 5/20, p = 0.04). No VAC related complications occurred.

Conclusion

Postoperative application of a VAC embedded in a perioperative treatment protocol has the potential to prevent wound dehiscence of the neoanus and reconstructed perineal body following PSARP.

Type of study

Case–control study.

Level of evidence

Level III.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →